This phase 3 trial studies how well active surveillance help doctors to monitor subjects with low-risk germ cell tumors for recurrence after their tumor is removed. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy in treating germ cell tumors.

We would like to rely on CIRB as the IRB of record for this study.

You may be eligible for this study if you meet the following criteria:

• Conditions: Medical Research
• Age: - 99 Years
• Gender: All